Radiodermatitis
27
1
1
12
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
3 terminated out of 27 trials
80.0%
-6.5% vs benchmark
11%
3 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (27)
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.
Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis.
Patient Reported Outcomes Using Mepitel Film During Radiotherapy
Development of a Protective Cream Against Radiodermatitis Caused by Radiotherapy.
Thermal Imaging to Evaluate Skin Toxicity From Radiotherapy
Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy
Clinical Trial of The Use of Bolus in Post Mastectomy Irradiation in Breast Cancer
Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.
A Novel Skin Barrier Protectant for Acute Radiodermatitis
Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy
Photobiomodulation for Breast Cancer Radiodermatitis
Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®
Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.
Management Radiodermatitis in Patients With Breast or Head and Neck Cancer
Preventive Effect of Boron-based Gel on Radiation Dermatitis
Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients
Evaluation of Fenofibrate on Radiation-induced Skin Injury
Topical Use of Difinsa53™ to Prevent Radiation Dermatitis
Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients